3,962 Shares in Ryan Specialty Holdings, Inc. (NYSE:RYAN) Bought by Virtu Financial LLC

Virtu Financial LLC acquired a new stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 3,962 shares of the company’s stock, valued at approximately $263,000.

Other large investors have also recently made changes to their positions in the company. Principal Financial Group Inc. lifted its stake in Ryan Specialty by 148.9% in the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company’s stock valued at $56,545,000 after purchasing an additional 509,548 shares during the last quarter. Bank of New York Mellon Corp raised its stake in shares of Ryan Specialty by 132.2% in the second quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company’s stock valued at $48,425,000 after buying an additional 476,126 shares during the period. Jennison Associates LLC lifted its position in shares of Ryan Specialty by 60.2% during the 3rd quarter. Jennison Associates LLC now owns 1,025,063 shares of the company’s stock valued at $68,054,000 after buying an additional 385,366 shares during the last quarter. Eagle Asset Management Inc. grew its stake in shares of Ryan Specialty by 32.1% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,380,510 shares of the company’s stock worth $98,555,000 after acquiring an additional 335,180 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its holdings in Ryan Specialty by 43.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 938,187 shares of the company’s stock worth $62,286,000 after acquiring an additional 286,380 shares during the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on RYAN. BMO Capital Markets raised shares of Ryan Specialty from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $65.00 to $75.00 in a report on Tuesday, September 24th. The Goldman Sachs Group raised their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a report on Wednesday, October 9th. Bank of America boosted their target price on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Morgan Stanley began coverage on Ryan Specialty in a report on Thursday, December 5th. They issued an “overweight” rating and a $90.00 price target for the company. Finally, Barclays boosted their price objective on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $73.50.

Ryan Specialty Trading Down 1.5 %

Shares of RYAN stock opened at $65.44 on Wednesday. The business has a 50-day moving average price of $70.69 and a two-hundred day moving average price of $64.71. Ryan Specialty Holdings, Inc. has a 12-month low of $41.57 and a 12-month high of $75.97. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The firm has a market cap of $17.13 billion, a P/E ratio of 84.99, a price-to-earnings-growth ratio of 1.52 and a beta of 0.67.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.41. The business had revenue of $604.69 million during the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s revenue for the quarter was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 earnings per share. Equities analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s payout ratio is presently 57.14%.

Insiders Place Their Bets

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $67.39, for a total value of $2,358,650.00. Following the transaction, the director now directly owns 65,100 shares of the company’s stock, valued at $4,387,089. The trade was a 34.97 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David P. Bolger sold 7,055 shares of the stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. This trade represents a 8.28 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 91,845 shares of company stock valued at $6,249,417 over the last three months. Insiders own 11.10% of the company’s stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.